
Product Description
Janssen-Cilag International NV
VECTOR MODIFIED VACCINIA ANKARA VACCINE, MULTIVALENT, LIVE, RECOMBINANT, NON-REPLICATIVE IN HUMAN CELLS, EXPRESSING THE GLYCOPROTEINS (GP) OF EBOLA MAYINGA VIRUSES, SUDAN GULU, MARBURG, NUCLUS, AND FOREST MUSOPE VIRUSES